Seno Medical Instruments Raises $34.6M

San Antonio-based Seno Medical, a developer of opto-acoustic imaging equipment used for diagnosing breast cancer, has raised $34.6M as part of a Series C funding round, which is targeted at $39M, the company said Tuesday. The funding was led by MedCare Investment Funds. The company said the firm's existing investors also participated. Seno Medical said the funding will go towards its U.S. Pivotal Study of its equipment, and CE Marking activities in Europe. Seno Medical's equipment combines light and osund with conventional ultrasound to better map out suspicious masses in cancer diagnostics. More information »